Cancer Treatment Reviews
Volume 36, Issue 4 , Pages 348-353, June 2010

The contribution of the Epstein-Barr virus to the pathogenesis of childhood lymphomas

Cancer Research UK Institute for Cancer Studies, School of Cancer Sciences, University of Birmingham, Birmingham B15 2TT, UK

published online 02 March 2010.

Summary 

The Epstein-Barr virus (EBV) is a lymphotropic herpes virus with oncogenetic properties which can lead to the development of lymphomas such as Burkitt’s lymphoma (BL), Hodgkin’s lymphoma (HL), or post-transplant lymphoma. This review discusses our current understanding of lymphomagenesis in relation to EBV and the potential for targeted therapies.

Keywords: EBV, Lymphoma, Childhood, Herpes virus, Therapy

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0305-7372(10)00031-9

doi:10.1016/j.ctrv.2010.02.011

Cancer Treatment Reviews
Volume 36, Issue 4 , Pages 348-353, June 2010